Physical Medicine & Rehabilitation Doctors in La Mesa, CA Accepting Medicare

6 Physical Medicine & Rehabilitation doctors found. Showing 1 - 6

Dr. Johnathan S. Halperin, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5525 Grossmont Center Dr, La Mesa, CA 91942 Phone: 619-644-6826    Fax: 619-644-1208

Roxanne Audrey Hon, MD INC Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8030 La Mesa Blvd, #143, La Mesa, CA 91942 Phone: 619-697-7900    Fax: 619-462-6428

Thomas Joon Gallagher, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7862 El Cajon Blvd Ste 1, La Mesa, CA 91942 Phone: 619-697-3093

Nicholas L Schroeder, PT, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8881 Fletcher Pkwy Ste 385, La Mesa, CA 91942 Phone: 619-460-0137    Fax: 619-460-0139

David Gerard O'malley, MD Physical Medicine & Rehabilitation - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 8881 Fletcher Pkwy Ste 290, La Mesa, CA 91942 Phone: 619-461-3200    Fax: 619-461-3201

Dr. Franklin Kalmar, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 5696 Lake Murray Blvd, La Mesa, CA 91942 Phone: 619-460-5225    Fax: 619-460-4810

News Archive

Shire's INTUNIV (Guanfacine) approved by the FDA for treatment of Attention-Deficit/Hyperactivity Disorder

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV- (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years. INTUNIV, a once-daily formulation of guanfacine, is the first selective alpha-2A adrenergic receptor agonist approved for the treatment of ADHD.

Viewpoints: Anti-abortion Democrats praise health law; A defense of the Medicare cost-cutting board

The big question heading into the Democratic Convention is just how forcefully the party will defend the Affordable Care Act, which the president fought to pass and then declined to sell. On Tuesday, an unusually vocal endorsement of the law came from an unlikely source: Anti-abortion Democrats.

Tokai raises $23M in Series D3 financing

Tokai Pharmaceuticals, a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that it has raised $23 million in a Series D3 financing.

Strategic solutions for hospitals to meet Joint Commission and CMS Requirements

Ultimus, Inc., a leading provider of Business Process Management (BPM) Solutions, will host a webcast focusing on how Process Automation can help hospitals achieve compliance with Joint Commission and CMS Requirements in 2010. Norma Kay Sprayberry will discuss how increasing demands for improved health care and greater patient satisfaction are driving changes in Joint Commission standards and raising the bar for hospital performance.

Consequences of secrecy in medicine

No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.

Read more Medical News

› Verified 5 days ago